Zobrazeno 1 - 10
of 39
pro vyhledávání: '"HengSheng Fang"'
Autor:
Adam D. Wegman, Hengsheng Fang, Alan L. Rothman, Stephen J. Thomas, Timothy P. Endy, Michael K. McCracken, Jeffrey R. Currier, Heather Friberg, Gregory D. Gromowski, Adam T. Waickman
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Dengue virus (DENV) is a prevalent human pathogen, infecting approximately 400 million individuals per year and causing symptomatic disease in approximately 100 million. A distinct feature of dengue is the increased risk for severe disease in some in
Externí odkaz:
https://doaj.org/article/4682c9b4478a45098e43e2013851ecef
Autor:
Adam T. Waickman, Joseph Lu, Corey Chase, Hengsheng Fang, Erinn McDowell, Erin Bingham, Jeffrey Bogart, Stephen Graziano, Stephen J. Thomas, Teresa Gentile
Publikováno v:
Vaccines, Vol 10, Iss 5, p 738 (2022)
mRNA vaccines have been shown to be safe and effective in individuals with cancer. It is unclear, however, if systemic anti-cancer therapy impacts the coordinated cellular and humoral immune responses elicited by SARS-CoV-2 mRNA vaccines. To fill thi
Externí odkaz:
https://doaj.org/article/a1f8162a6157462392193182b7d4dac9
Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity
Autor:
Hengsheng Fang, Adam D. Wegman, Kianna Ripich, Heather Friberg, Jeffrey R. Currier, Stephen J. Thomas, Timothy P. Endy, Adam T. Waickman
Publikováno v:
Viruses, Vol 13, Iss 5, p 916 (2021)
SARS-CoV-2 represents an unprecedented public health challenge. While the majority of SARS-CoV-2-infected individuals with mild-to-moderate COVID-19 resolve their infection with few complications, some individuals experience prolonged symptoms lastin
Externí odkaz:
https://doaj.org/article/25e590313acc49eeb04c7f7643deed32
Autor:
Adam T. Waickman, Krista Newell, Joseph Q. Lu, HengSheng Fang, Mitchell Waldran, Chad Gebo, Jeffrey R. Currier, Heather Friberg, Richard G. Jarman, Michelle D. Klick, Lisa A. Ware, Timothy P. Endy, Stephen J. Thomas
Dengue human infection models present an opportunity to explore a vaccine, antiviral, or immuno-compound’s potential for clinical benefit in a controlled setting. Herein, we report the outcome of a phase 1, open-label assessment of a DENV-3 challen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aeefc76f7f6e0503804baf80b216daf4
https://doi.org/10.1101/2022.10.24.22281454
https://doi.org/10.1101/2022.10.24.22281454
Autor:
Adam T. Waickman, Joseph Q. Lu, HengSheng Fang, Mitchell J. Waldran, Chad Gebo, Jeffrey R. Currier, Lisa Ware, Liesbeth Van Wesenbeeck, Nathalie Verpoorten, Oliver Lenz, Lotke Tambuyzer, Guillermo Herrera-Taracena, Marnix Van Loock, Timothy P. Endy, Stephen J. Thomas
Publikováno v:
Science Translational Medicine. 14
Dengue virus (DENV) infections are major causes of morbidity and mortality throughout the tropics and subtropics. More than 400 million infections are estimated to occur every year, resulting in nearly 100 million symptomatic infections and more than
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8089c7c71224c89ad5d33c410686e4e
https://doi.org/10.1126/scitranslmed.abo5019
https://doi.org/10.1126/scitranslmed.abo5019
Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity
Autor:
Heather Friberg, Adam D. Wegman, Adam T. Waickman, Hengsheng Fang, Timothy P. Endy, Kianna Ripich, Jeffrey R. Currier, Stephen J. Thomas
Publikováno v:
Viruses, Vol 13, Iss 916, p 916 (2021)
Viruses
Volume 13
Issue 5
Viruses
Volume 13
Issue 5
SARS-CoV-2 represents an unprecedented public health challenge. While the majority of SARS-CoV-2-infected individuals with mild-to-moderate COVID-19 resolve their infection with few complications, some individuals experience prolonged symptoms lastin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bef4353443f92101820929fbaa99b4f
https://www.mdpi.com/1999-4915/13/5/916
https://www.mdpi.com/1999-4915/13/5/916
Autor:
Hengsheng Fang, Jeffrey R. Currier, Kianna Ripich, Heather Friberg, Adam D. Wegman, Stephen J. Thomas, Adam T. Waickman, Timothy P. Endy
SARS-CoV-2 represents an unprecedented public health challenge with many unknowns remaining regarding the factors that impact viral pathogenicity and the development of immunity after infection. While the majority of SARS-CoV-2 infected individuals w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87a4072820b4f2af294f489aba4fe323
https://doi.org/10.1101/2021.01.29.21250771
https://doi.org/10.1101/2021.01.29.21250771
Autor:
Adam T Waickman, Joseph Q Lu, HengSheng Fang, Mitchell J Waldran, Chad Gebo, Liesbeth Van Wesenbeeck, Nathalie Verpoorten, Oliver Lenz, Lotke Tambuyzer, Guillermo Herrera-Taracena, Marnix Van Loock, Timothy P Endy, Stephen J Thomas
Publikováno v:
The Journal of Immunology. 208:126.21-126.21
Dengue virus (DENV) is a significant source of morbidity and mortality throughout the tropics and subtropics. Over 400 million infections are thought to occur every year, resulting in nearly 100 million symptomatic infections and over 20,000 deaths.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0616f97c4223b9e85266b2c584b1e63b
https://doi.org/10.4049/jimmunol.208.supp.126.21
https://doi.org/10.4049/jimmunol.208.supp.126.21
Autor:
Mark Abbott, Mark Polhemus, Richard G. Jarman, Dongliang Wang, Lisa Ware, Paul B. Keiser, Timothy P. Endy, Stephen J. Thomas, Don Cibula, Hengsheng Fang
Publikováno v:
The Journal of infectious diseases. 221(9)
Background The World Health Organization recommends intradermal (ID) administration of rabies vaccine for preexposure prophylaxis. Methods In a randomized trial in adults assigned to 1 of 6 treatment groups (ID vs intramuscular [IM], 2 vs 3 doses, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78822b19611292ad9b14f2e80c9adde6
https://pubmed.ncbi.nlm.nih.gov/31802120
https://pubmed.ncbi.nlm.nih.gov/31802120
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 5, Iss Suppl E, Pp 29E-33E (1994)
In vitro selection in MT-4 cells was used to generate human immunodeficiency virus-type 1 (HIV 1) variants that are resistant to 2',3'-dideoxycytidine (ddC), 2',3'-didcoxyinosine (ddI) and the (-) enantiomer of 2' ,3'-dideoxy-3'-thiacytidine (3TC). T
Externí odkaz:
https://doaj.org/article/04acaa5b28314266b4eeaabb0ae864f1